Assessing the prognostic value of carcinoembryonic antigen levels in stage I and II colon cancer
Ofer Margalit(Sheba Medical Center), Ben Boursi(Tel Aviv University), Yu‐Xiao Yang(Philadelphia VA Medical Center), Ronac Mamtani(Hospital of the University of Pennsylvania), Dan Aderka(Sheba Medical Center), Einat Shacham‐Shmueli(Sheba Medical Center), Talia Golan(Sheba Medical Center), Kim A. Reiss(University of Pennsylvania), Bruce J. Giantonio(Northwestern University), Naama Halpern(Tel Aviv University)
Cited by 48
Related Papers
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k